These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16158968)

  • 1. Antileukemic activity of glycated fibrinogen-methotrexate conjugates.
    Kanska U; Omar MS; Budzynska R; Nevozhay D; Jagiello M; Opolski A; Boratynski J
    Anticancer Res; 2005; 25(3B):2229-34. PubMed ID: 16158968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antileukemic activity of modified fibrinogen-methotrexate conjugate.
    Goszczyński T; Nevozhay D; Wietrzyk J; Omar MS; Boratyński J
    Biochim Biophys Acta; 2013 Mar; 1830(3):2526-30. PubMed ID: 23168301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic and antitumor effect of fibrinogen-methotrexate conjugate.
    Boratyński J; Opolski A; Wietrzyk J; Górski A; Radzikowski C
    Cancer Lett; 2000 Feb; 148(2):189-95. PubMed ID: 10695996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor properties and toxicity of dextran-methotrexate conjugates are dependent on the molecular weight of the carrier.
    Nevozhay D; Budzynska R; Kanska U; Jagiello M; Omar MS; Boratynski J; Opolski A
    Anticancer Res; 2006; 26(2A):1135-43. PubMed ID: 16619515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the substitution level of some dextran-methotrexate conjugates on their antitumor activity in experimental cancer models.
    Nevozhay D; Budzynska R; Jagiello M; Kanska U; Omar MS; Opolski A; Wietrzyk J; Boratynski J
    Anticancer Res; 2006; 26(3A):2179-86. PubMed ID: 16827162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of dendrimer-methotrexate conjugates on methotrexate-sensitive and -resistant cell lines.
    Gurdag S; Khandare J; Stapels S; Matherly LH; Kannan RM
    Bioconjug Chem; 2006; 17(2):275-83. PubMed ID: 16536456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibition, drug load, and degradation studies of gelatin/methotrexate conjugates.
    Ofner CM; Pica K; Bowman BJ; Chen CS
    Int J Pharm; 2006 Feb; 308(1-2):90-9. PubMed ID: 16361072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyethylene glycol conjugates of methotrexate varying in their molecular weight from MW 750 to MW 40000: synthesis, characterization, and structure-activity relationships in vitro and in vivo.
    Riebeseel K; Biedermann E; Löser R; Breiter N; Hanselmann R; Mülhaupt R; Unger C; Kratz F
    Bioconjug Chem; 2002; 13(4):773-85. PubMed ID: 12121133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of fibrinogen-methotrexate derivatives on HeLa cell growth.
    Dyr JE; Hermanová E; Slavík K; Vodrázka Z
    Neoplasma; 1986; 33(4):401-7. PubMed ID: 3531894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cancer chemotherapy for lymph nodal metastases using activated carbon particles adsorbing methotrexate].
    Hagiwara A; Takahashi T; Sawai K; Shimotsuma M; Okano S; Sakakura C; Ozaki K; Tsujimoto H; Sasaki S; Shirasu M
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1595-7. PubMed ID: 1530314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chiral selectivity in differentiation of lung cancer A549 cell to vascular endothelial cells after drug resistance induced by D-or L-methotrexate enantiomers].
    He XD; Hu SL; Shen ZJ; Tao SN; Dong L; Zhu YY; Li M
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):690-4. PubMed ID: 19595065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing methotrexate resistance by combination of active-site mutations in human dihydrofolate reductase.
    Volpato JP; Fossati E; Pelletier JN
    J Mol Biol; 2007 Oct; 373(3):599-611. PubMed ID: 17868689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intratumoral administration of methotrexate bound to activated carbon particles (MTX-CH) inducing antitumor effect in vivo].
    Nakase Y; Kin S; Fukuda K; Takagi T; Shimomura K; Ito T; Sakakura C; Otsuji E; Ueda Y; Sonoyama T; Itoi H; Hagiwara A; Yamagishi H
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1859-61. PubMed ID: 14619539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemotherapy of C3H mice bearing Gardner lymphosarcoma with bovine fibrinogen-methotrexate derivative.
    Motycka K; Slavík K; Dyr JE; Balcarová A; Vodrázka Z
    Neoplasma; 1981; 28(1):3-10. PubMed ID: 6895104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antileukemic activity of sulfonamide conjugates of arabinosylcytosine.
    Novotny L; Phillips OA; Rauko P; Miadokova E
    Exp Oncol; 2006 Dec; 28(4):293-8. PubMed ID: 17285113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects and interaction of 7-hydroxy methotrexate and methotrexate in leukaemic cells ex vivo measured by the thymidylate synthase inhibition assay.
    Lingg RM; Hempel G; Rots MG; Van Zantwijk CH; Boos J; Kaspers GJ
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):322-7. PubMed ID: 15868145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate-induced apoptosis is enhanced by altered expression of methylenetetrahydrofolate reductase.
    Celtikci B; Lawrance AK; Wu Q; Rozen R
    Anticancer Drugs; 2009 Oct; 20(9):787-93. PubMed ID: 19593106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local administration of methotrexate bound to activated carbon particles (MTX-CH) for treating cancers in mice.
    Ito T; Hagiwara A; Takagi T; Fujiyama J; Sonoyama Y; Shimomura K; Takemura M; Toma A; Kin S; Nakase Y; Yamagishi H
    Anticancer Res; 2003; 23(2B):1401-4. PubMed ID: 12820401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ distribution of fibrinogen-bound methotrexate in mice with Gardner lymphosarcoma.
    Slavíková V; Dyr JE; Motycka K; Pristoupilová K; Holý P; Slavík K
    Neoplasma; 1987; 34(3):269-76. PubMed ID: 3614463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity studies in vivo of liposomal phospholipid-N4-palmitoyl- and N4-hexadecyl-1-beta-D-arabinofuranosylcytosine conjugates.
    Schott H; Schwendener RA
    Anticancer Drug Des; 1996 Sep; 11(6):451-62. PubMed ID: 8836110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.